Calendar PHARMAGEST INTER. Euronext Paris
Stocks
FR0000077687
IT Services & Consulting
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 09-28 | Equasens improves margins in the first half |  |
| 09-23 | French and Benelux stocks-Factors to watch Sept 23 | RE |
Upcoming events on PHARMAGEST INTER.
| 2026-10-28 | Sales and Revenue Release - Q3 2026 | AH |
Past events on PHARMAGEST INTER.
| 2026-09-28 | Earnings release - Q2 2026 | |
| 2026-09-27 | Earnings presentation | |
| 2026-09-22 | Board of Directors Meeting | |
| 2026-07-29 | Sales and Revenue Release - Q2 2026 | AH |
| 2026-06-25 | Annual General Meeting | 03:30 |
| 2026-06-25 | Présentation aux Actionnaires / Analystes | 03:30 |
| 2026-06-24 | Information meeting | |
| 2026-06-24 | Board of Directors Meeting | |
| 2026-04-28 | Sales and Revenue Release - Q1 2026 | AH |
| 2026-03-30 | Earnings release - Annual 2025 | |
| 2026-03-29 | Earnings presentation | |
| 2026-03-26 | Board of Directors Meeting | |
| 2026-02-04 | Sales and Revenue Release - Annual 2025 | |
| 2026-02-04 | Sales and Revenue Release - Annual 2025 | |
| 2025-11-04 | Sales and Revenue Release - Q3 2025 |
Past dividends on PHARMAGEST INTER.
| 2026-07-01 | Ex-dividend date - 1.4 EUR | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 220 223 -1.58% | 217 217 -0.28% | 237 236 0.24% | 254 | 269 | 279 |
|
EBITDA Million EUR | Released Forecast Spread | 69,4 69,0 0.58% | 58,4 60,5 -3.52% | 0,00 64,5 - | 70,2 | 77,0 | 81,4 |
|
EBIT Million EUR | Released Forecast Spread | 55,8 55,1 1.2% | 45,1 44,9 0.39% | 48,2 47,4 1.64% | 53,7 | 58,5 | 61,4 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 57,4 55,6 3.34% | 47,1 46,8 0.72% | 0,00 47,2 - | 57,5 | 64,5 | 71,2 |
|
Net income Million EUR | Released Forecast Spread | 47,0 45,9 2.45% | 36,2 38,3 -5.59% | 39,3 37,1 5.93% | 44,1 | 49,3 | 51,7 |
|
EPS EUR | Released Forecast Spread | 3,13 3,07 2.03% | 2,39 2,55 -6.44% | 0,00 2,45 - | 2,97 | 3,30 | 3,48 |
| Announcement Date | 29/03/24 | 28/03/25 | 30/03/26 | - |
Quarterly results
| Fiscal Period | December | 2025 Q1 | 2025 Q2 | 2025 S2 | 2026 Q1 | 2026 Q2 | 2026 S1 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 57,0 | 58,9 56,2 4.8% | 121 | 61,4 63,0 -2.54% | 64,2 | 126 |
|
EBIT Million EUR | Released Forecast Spread | 22,6 | |||||
| Announcement Date | 12/05/25 | 31/07/25 | 30/03/26 | 29/04/26 | - | - |
| Today |  | Extraordinary General Meeting | 11:30 |
| 2026-10-07 | | Board of Directors Meeting | |
| 2026-10-07 | | Significant Split/Dividend | 00:00 |
| 2026-10-08 | | Earnings release - Q2 2027 | |
| 2026-10-08 | | Earnings presentation | 09:30 |
| 2026-10-08 | | Extraordinary General Meeting | |
| 2026-10-08 | | Extraordinary General Meeting | 03:00 |
| 2026-10-08 | | Extraordinary General Meeting | 02:00 |
| 2026-10-09 | | Ex-dividend date - 0.37 USD | 00:00 |
| 2026-10-09 | | Extraordinary General Meeting | 03:00 |
Past sector events for PHARMAGEST INTER.
| 2026-10-05 | | Présentation aux Actionnaires / Analystes | 06:30 |
| 2026-10-05 | | Extraordinary General Meeting | 06:30 |
| Today | | Extraordinary General Meeting | |
| 2026-10-04 | | Présentation aux Actionnaires / Analystes | 00:30 |
| 2026-10-04 | | Extraordinary General Meeting | 00:30 |
| 2026-10-01 | | Earnings presentation | 08:00 |
| 2026-10-01 | | Earnings release - Q4 2026 | |
| 2026-10-01 | | Ex-dividend date - 0.198 GBX | 00:00 |
| 2026-09-30 | | Information meeting | 04:30 |
| 2026-09-30 | | Ex-dividend date - 0.569 USD | 00:00 |
- Stock Market
- Stocks
- EQS Stock
- Stock
- Calendar PHARMAGEST INTER.
Select your edition
All financial news and data tailored to specific country editions
